7,300-year-old ancestor explains why Nigerians, Congolese and Indians most likely to get sickle cell anaemia

a d c e bdb ed b

A one-time gene mutation in a West African human millennia ago gave them immunity to malaria and doomed some of their descendants to sickle cell anaemia, according to new research.

Today, about 300,000 children are born with sickle cell anaemia every year, with that number expected to rise to 400,000 in the next 30 years. The majority of these cases occur in Nigeria, the Democratic Republic of Congo, and India, and many of these babies are likely to die from the disease in which their red blood cells break apart, leaving their bodies starved of oxygen. It is caused by two copies of a gene mutation in their DNA. One copy is harmless; two copies can be deadly. Millions of people worldwide, frequently those with African heritage, are carriers of this mutant gene, but there are large gaps in our knowledge of the disease and its characteristic mutations.

The new research shows the disease began with a single genetic mutation in a child born about 260 generations ago. Human DNA contains two copies of this gene, and when only one copy contains the mutation, carriers are better able to fend off malaria, something which was vital for survival on the African continent.

The new research, published in scientific journal Cell, has found that this disease began with a single ancestor who developed the mutation to fend off malaria.

Read full, original post: Everyone with the sickle cell gene mutation descended from the same ancestor 7,300 years ago

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.noReviewsLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Picture1
Hiroshima at 81: America’s new nuclear bomb, a buried Iranian target, and a question no one wants to ask
ChatGPT Image Jul 29, 2026, 05_50_04 PM
Fear, science, and the law: If talc powder is unlikely to cause cancer and J&J was winning in court, why did it pay more than $5.5 billion to settle?
ChatGPT Image Jul 29, 2026, 10_14_27 PM
After muzzling RFK, Jr. over autism-vaccine conspiracy theories, Trump defies aides to push scares again
Screenshot 2026-07-29 at 1.03
Two food fads that have some merit: Chia seeds in almost everything and protein added to water
ChatGPT Image Jul 29, 2026, 06_26_01 PM 2
Facts & Fallacies podcast: Organic food myths make a comeback on Instagram, with Dr. Kevin Folta
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
Screenshot-2026-07-09-at-1.09.25-PM
Anti-vaccine myths rattle health care
ChatGPT Image Jul 29, 2026, 10_31_48 PM
Bowing to Congressional pressure, Kennedy reverses himself and releases $600 million that helps developing countries buy and distribute vaccines
Screenshot 2026-07-28 at 3.43
Fat cat? GLP-1 weight loss drugs for animals are on the horizon
Screenshot 2026-07-28 at 3.22
Hidden hunger: Climate change is speeding up the decline of important nutrients in our food
Screenshot 2026-07-22 at 1.38
Viewpoint: Are the U.S. and Europe headed towards a repudiation of agricultural biotechnology red tape?
organic scaled
Facts & Fallacies podcast: Organic food cuts pesticide exposure? A response to Dr. Rhonda Patrick
ChatGPT-Image-Jul-10-2026-09_42_12-AM-1
Peptides, patient autonomy, and the limits of medical freedom
Screenshot 2026-07-27 at 6.15
No test, no tennis: Women’s Tennis Association becomes first major female sports league to require genetic sex testing
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.